Arthroscopic Raman Monitoring of Cartilage Content for PTOA Diagnosis and Regenerative Treatment Response
Official title: Arthroscopic Raman Monitoring of Cartilage Content for PTOA Diagnosis and Chondroregenerative Treatment Response
Funded at Boston University (Charles River Campus) · NIH-11401161 · Data updated 2026-11-12
A new imaging approach during arthroscopy uses Raman spectroscopy to measure cartilage composition and track how well PTOA treatments are working after injury.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | August 2, 2022 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $598,227 |
| NIH project number | 5R01AR081393-05 |
| Project ID | NIH-11401161 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with traumatic joint injuries at risk for PTOA who are undergoing arthroscopic procedures or related cartilage interventions.
✕Less likely to help
Patients not undergoing procedures that involve cartilage assessment or those without PTOA risk may not benefit.
What this research studies
This project uses arthroscopic Raman spectroscopy to directly assess the biochemical makeup of cartilage during joint procedures. By comparing Raman signals with known cartilage properties, doctors may be able to diagnose post-traumatic osteoarthritis earlier and monitor how well chondroregenerative treatments are performing. The study translates advanced spectroscopy into a clinically feasible tool that could guide treatment choices and improve patient outcomes. If successful, it could lead to more precise, personalized care for people after joint injuries.
Why it matters
Potential benefit: If successful, patients could receive earlier PTOA diagnosis and better-informed, potentially more effective treatment decisions.
How similar studies have gone: Previous work suggests Raman-based cartilage assessment shows promise, but clinical translation to routine PTOA care is still evolving.
Where this research is happening
-
Boston University (Charles River Campus)
Boston, United States Active
Researchers
- Principal investigator: Albro, Michael B — Boston University (Charles River Campus)
- Study coordinator: Albro, Michael B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.